DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease

Blood Cancer Journal, Published online: 27 January 2023; doi:10.1038/s41408-022-00781-8DNA-PK hyperactivation occurs in deletion 11q chronic lymphocytic leukemia and is both a biomarker and therapeutic target for drug-resistant disease

Source: Blood Cancer Journal - January 27, 2023 Category: Hematology Authors: Sara E. F. Kost Ali Saleh Shek H. Yuan Bozena Kuzio Spencer B. Gibson Lin Yang Versha Banerji James B. Johnston Sachin Katyal Source Type: research